De Groen PC, Lubbe DF, Hirch LJ, et al. Esophagitis Associated with the Use of Alendronate. N Engl J Med 1996; 335: 1016-1021.
Lubbe DF, Schwartz RS. The Platelet in Acute Coronary Syndromes. The Circulation Frontier 1999;3:26-33
Schwartz RS, Lubbe DF, Altman JD, Holmes DR. Local Arterial Drug Delivery: A Golden Gun Without Bullets? J Inv Card.1999;11(10) 620-621.
Bayes-Genis A, Kantor B, Keelan PC, Altman JD, Lubbe DF, Kang JH, Schwartz RS. Restenosis and Hyperplasia: Animal Models. Curr Interv Cardiol Rep. 2000;2:303-308.
Lubbe DF, Holmes DR. Prevention of Restenosis after Percutaneous Coronary Intervention. ACC Current Journal Review 2001;10(1)39-42
Altman JD, Lubbe DF, Kantor B, Holmes D, Schwartz RS. Soft X-rays. The Alternative? J Interven Cardiol; 2000;13: 431-438.
Lubbe DF, Berger PB. The ‘Initial Invasive’ Approach to the Management of Patients with Non-ST Segment Elevation Acute Coronary Syndromes . Acute Coronary Syndromes 4.1 Nov 2001
Lubbe DF, Berger PB. The Thienopyridines. J Interven Cardiol 2002;15:85–94
Mehrdad R, Yeung A, Altman P, Lubbe DF, Takeshi S, Schwartz RS, Stertzer S, Altman JD. Evaluation of the percutaneous intramyocardial injection for local myocardial treatment. Catheter Cardiovasc Interv 53;2:271-6
Lubbe DF, Kantor BK, Altman JD, Schwartz RS, Gersh BJ. Reperfusion Injury: Pathophysiology, Clinical Implications and Approaches to Management (in review- JACC)
Lubbe DF, Bell MR, Holmes DR, Berger PB. Coronary Angiographic Characteristics Among Patients Undergoing Surgical Revascularization for Left Main Coronary Artery Disease: Suitability for Percutaneous Revascularization with Stents. (In review, American Heart Journal)
The Patient Rating score is based on responses given during the CAHPS Patient Experience Survey.Responses are measured on a 10 - point scale, with 10 being the best score. These scores are then translated to a 5 - point scale in order to display results in a 5 - star rating.Comments are also gathered from the same survey and displayed in their entirety with the exception of any language that may be considered slander, libel or contain private health information, which will be removed prior to publishing the comments.